The Universal stress protein F (uspF) is a member of the universal stress protein family in Escherichia coli that plays crucial roles in bacterial stress response mechanisms. It is involved in ATP binding, cell adhesion, and response to oxidative stress pathways . The significance of uspF lies in its activation during various stress conditions, making it an excellent model for studying bacterial adaptation mechanisms. The protein's well-determined NMR solution structure (Saveanu, 2002) provides a foundation for structure-function relationship studies in bacterial stress responses .
The uspF Antibody (PACO34502) is a rabbit-derived polyclonal antibody specifically targeting the Universal stress protein F from Escherichia coli. It is supplied as a liquid formulation (50μg) in a storage buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 . The antibody has been purified to >95% purity using Protein G chromatography and has been validated for ELISA applications . The immunogen used for antibody production was recombinant Escherichia coli Universal stress protein F protein spanning amino acids 1-144 .
For optimal performance and longevity of the uspF Antibody (PACO34502), proper storage and handling are essential:
Store the antibody at -20°C for long-term storage
When working with the antibody, keep it on ice and minimize freeze-thaw cycles
If frequent use is anticipated, prepare small aliquots to avoid repeated freeze-thaw cycles
The presence of 50% glycerol in the storage buffer helps prevent freezing at -20°C and maintains antibody stability
Prior to use, gently mix the antibody solution (avoid vortexing to prevent protein denaturation)
When diluting, use fresh, sterile buffers to prevent contamination
The uspF Antibody (PACO34502) has been validated for ELISA applications specifically . While dilution recommendations depend on the specific experimental context, general guidelines include:
| Application | Recommended Dilution Range | Optimization Notes |
|---|---|---|
| ELISA | 1:1,000 - 1:10,000 | Titration recommended for each specific assay |
| Western Blot | Not explicitly validated | If attempting, start with 1:500 - 1:2,000 |
Researchers should perform titration experiments to determine optimal concentrations for their specific experimental conditions. When using this antibody in applications beyond ELISA, validation experiments should be conducted to establish specificity and sensitivity in the new application context .
The uspF antibody can be employed in several sophisticated experimental approaches to elucidate stress response mechanisms:
Comparative stress profiling: Use ELISA with the uspF antibody to quantify uspF protein levels across different stress conditions (oxidative, nutrient deprivation, pH, temperature) to establish stress-specific response profiles.
Temporal expression analysis: Combine the antibody with time-course experiments to map the kinetics of uspF expression during stress adaptation, providing insights into the temporal dynamics of bacterial stress responses.
Co-immunoprecipitation studies: Utilize the antibody to isolate uspF protein complexes, followed by mass spectrometry to identify interaction partners under different stress conditions, revealing stress-specific protein-protein interaction networks.
Subcellular localization: Apply immunofluorescence techniques with the uspF antibody to track protein redistribution during stress responses, illuminating spatial regulation mechanisms.
Implementation of these approaches requires careful experimental design, including appropriate controls and optimization of antibody concentrations for each specific application .
When researchers encounter non-specific binding issues with the uspF antibody, systematic troubleshooting should include:
Optimization of blocking conditions: Test different blocking agents (BSA, non-fat milk, commercial blockers) at various concentrations and incubation times.
Stringency adjustment: Modify washing buffer composition by increasing salt concentration (150mM to 500mM NaCl) or adding mild detergents (0.1-0.5% Tween-20).
Antigen competition assays: Pre-incubate the antibody with recombinant uspF protein prior to application to confirm binding specificity.
Cross-reactivity assessment: Test the antibody against lysates from uspF knockout strains to evaluate potential cross-reactivity with other universal stress proteins.
Titration series: Perform systematic dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) to identify the optimal antibody concentration that maximizes specific signal while minimizing background.
These approaches should be implemented methodically, changing one parameter at a time while maintaining appropriate controls to identify the source of non-specific binding .
Integration of uspF antibody-based techniques into multi-omics research frameworks enables comprehensive characterization of bacterial stress responses:
Antibody-based proteomics with transcriptomics: Correlate uspF protein levels (via ELISA) with uspF gene expression (via RT-qPCR or RNA-seq) to identify post-transcriptional regulation mechanisms during stress responses.
Phosphoproteomics integration: Combine immunoprecipitation using uspF antibody with phosphoproteomic analysis to detect stress-induced phosphorylation of uspF and associated proteins, revealing signaling cascades activated during stress.
Metabolomics correlation: Align uspF expression patterns with metabolomic profiles to establish connections between stress protein activities and metabolic adaptations.
Chromatin immunoprecipitation sequencing (ChIP-seq): If uspF acts as a transcriptional regulator during stress, use the antibody in ChIP-seq experiments to map genome-wide binding sites and identify regulated genes.
This integrated approach requires careful experimental design and sophisticated data integration strategies to generate meaningful insights about bacterial stress response networks .
When extending uspF antibody applications beyond the validated Escherichia coli systems, researchers should consider:
Sequence homology analysis: Perform bioinformatic analysis of uspF protein sequence conservation across target species to predict potential cross-reactivity.
Epitope mapping: If possible, determine the specific epitopes recognized by the antibody and assess their conservation in target species.
Validation experiments: Conduct Western blot analysis using lysates from multiple bacterial species alongside E. coli controls to empirically determine cross-reactivity.
Competitive binding assays: Perform pre-absorption controls with recombinant uspF proteins from different species to assess binding specificity.
Knockout controls: Where available, include uspF knockout strains of the target species as negative controls to confirm antibody specificity.
The table below summarizes predicted cross-reactivity based on uspF sequence conservation:
| Bacterial Species | uspF Sequence Identity to E. coli | Predicted Cross-Reactivity | Validation Approach |
|---|---|---|---|
| E. coli strains | 95-100% | High | Western blot |
| Salmonella spp. | 80-85% | Moderate | Western blot with competing peptide controls |
| Shigella spp. | 90-95% | High | Western blot |
| Pseudomonas spp. | 45-50% | Low | Pre-absorption controls necessary |
| Bacillus spp. | 30-35% | Very low | Not recommended without extensive validation |
These considerations help ensure experimental rigor when extending research beyond the validated species reactivity .
For quantitative ELISA experiments using the uspF antibody, the following optimized protocol is recommended:
Plate preparation: Coat high-binding 96-well plates with target antigens (50-100 μl/well) in carbonate-bicarbonate buffer (pH 9.6) overnight at 4°C.
Blocking: Block with 1-3% BSA or 5% non-fat milk in PBS for 1-2 hours at room temperature.
Primary antibody: Apply uspF antibody at optimized dilution (starting recommendation: 1:5,000) in blocking buffer for 1-2 hours at room temperature or overnight at 4°C.
Washing: Wash 4-5 times with PBS-T (PBS + 0.05% Tween-20).
Secondary antibody: Apply HRP-conjugated anti-rabbit IgG at 1:5,000-1:10,000 dilution for 1 hour at room temperature.
Development: Add TMB substrate and monitor colorimetric development, stopping the reaction with 2N H₂SO₄ when appropriate.
Analysis: Read absorbance at 450nm and generate standard curves using purified recombinant uspF protein.
Critical aspects for optimization include:
Performing antibody titration to determine optimal working concentration
Including recombinant uspF protein standards (5-500 ng/ml range)
Running technical triplicates for each experimental condition
A comprehensive experimental design for investigating uspF expression under various stress conditions should include:
Stress condition panel: Establish a matrix of stress conditions including:
Oxidative stress (H₂O₂: 0.1-5 mM)
Nutrient deprivation (carbon, nitrogen, phosphate limitation)
pH stress (pH 4.5-8.5)
Temperature stress (16°C-42°C)
Osmotic stress (NaCl: 0.1-0.5 M)
Time-course sampling: Collect samples at multiple time points (0, 15, 30, 60 min, 2, 4, 8, 24 hours) to capture both immediate and adaptive responses.
Multi-level analysis:
Protein level: ELISA with uspF antibody
mRNA level: RT-qPCR for uspF transcript
Activity assays: If applicable based on protein function
Controls:
Unstressed cultures processed in parallel
Known stress-responsive control proteins (e.g., RpoS)
Housekeeping genes/proteins for normalization
Replication strategy:
Minimum three biological replicates
Technical duplicates or triplicates for each measurement
This design enables comprehensive characterization of uspF involvement in various stress response pathways while maintaining experimental rigor through appropriate controls and replication .
When facing contradictory results in uspF protein quantification, researchers should implement this systematic troubleshooting framework:
Method triangulation: Validate results using multiple independent techniques:
ELISA with uspF antibody
Western blotting (if applicable)
Mass spectrometry-based quantification
Reference standard validation: Ensure recombinant protein standards maintain:
Proper folding and stability
Accurate concentration determination (BCA, Bradford, and amino acid analysis)
Lot-to-lot consistency
Sample preparation assessment:
Evaluate protein extraction efficiency across sample types
Test for extraction buffer compatibility with assay systems
Check for interfering compounds in complex samples
Technical variables control:
Standardize incubation times and temperatures
Use calibrated pipettes and validated reagents
Implement consistent plate washing techniques
Statistical approaches:
Apply robust statistical methods appropriate for data distribution
Identify and handle outliers systematically
Use power analysis to ensure adequate sample size
By methodically addressing these aspects, researchers can identify sources of variability and resolve contradictory results in uspF protein quantification studies .
Interpreting variations in uspF expression across different stress conditions requires nuanced analysis:
Expression pattern categorization:
Immediate response (0-30 minutes): Likely pre-existing regulatory mechanisms
Intermediate response (30 min-4 hours): Transcriptional regulation
Late response (>4 hours): Secondary adaptation or indirect regulation
Dose-response relationship analysis:
Linear relationships suggest direct stress sensing
Threshold responses indicate switch-like regulatory mechanisms
Non-monotonic responses may reflect complex feedback systems
Comparative stress analysis framework:
Stress-specific responses: Unique to particular stressors
General stress responses: Common across multiple stressors
Antagonistic responses: Opposite regulation by different stressors
Network context integration:
Correlate uspF expression with known stress response regulators
Compare timing with other stress-responsive proteins
Consider metabolic context and energy state of the cell
This interpretative framework helps distinguish between direct and indirect stress responses, regulatory mechanisms, and functional significance of uspF expression patterns in comprehensive stress response systems .
Rigorous quantification of uspF protein requires implementing these essential controls and standards:
Standard curve controls:
Purified recombinant uspF protein (1-144AA) at 7-8 concentrations spanning expected sample range
Prepare fresh standards for each assay to minimize degradation effects
Verify standard protein integrity by SDS-PAGE before use
Sample-specific controls:
Matrix-matched standards that account for sample composition effects
Spike-in recovery controls to assess detection efficiency in complex samples
Dilution linearity tests to identify interfering factors
Antibody performance controls:
Positive control: E. coli lysate with confirmed uspF expression
Negative control: uspF knockout E. coli strain lysate
Isotype control: Non-specific rabbit IgG at equivalent concentration
Technical validation controls:
Intra-assay replicates: Minimum triplicates within each plate
Inter-assay controls: Common samples across multiple experiments
Limit of detection determination: Serial dilutions to establish sensitivity
Normalization strategy:
Total protein normalization (BCA or Bradford assay)
Housekeeping protein quantification in parallel
Cell number or biomass normalization when appropriate
Implementation of this comprehensive control system ensures reliable and reproducible quantification of uspF protein across experimental conditions and between laboratories .
The uspF antibody can be strategically applied to investigate the role of uspF in biofilm formation and stress resistance through these advanced approaches:
Spatiotemporal expression profiling in biofilms:
Apply immunofluorescence with uspF antibody to visualize uspF distribution across biofilm layers
Combine with fluorescent stress reporters to correlate uspF expression with localized stress microenvironments
Use confocal microscopy to create 3D expression maps within biofilm structures
Stress resistance correlation studies:
Quantify uspF levels in biofilm vs. planktonic cells using ELISA
Compare expression before and after exposure to antimicrobials
Correlate uspF expression levels with survival rates following stress challenges
Genetic-proteomic integration:
Create uspF reporter strains with varying expression levels
Use uspF antibody to confirm protein levels in these strains
Correlate protein expression with biofilm formation capacity and stress resilience
Co-localization studies:
Apply dual immunofluorescence with uspF antibody and antibodies against known biofilm matrix components
Investigate protein-protein interactions between uspF and structural biofilm proteins
Track relocalization of uspF during biofilm maturation and stress adaptation
These approaches provide insights into how uspF contributes to the enhanced stress resistance observed in bacterial biofilms, potentially revealing new targets for antibiofilm strategies .
Emerging applications of uspF antibody in bacterial pathogenicity research include:
Host-pathogen interaction studies:
Track uspF expression during host cell infection using immunofluorescence
Correlate uspF levels with bacterial survival within phagocytes
Investigate uspF induction in response to host immune effectors
Virulence regulation mapping:
Examine uspF expression in response to host-mimicking conditions
Correlate uspF levels with virulence factor production
Investigate regulatory connections between stress response and virulence pathways
In vivo infection dynamics:
Apply immunohistochemistry with uspF antibody on infected tissue samples
Track uspF expression during different infection stages
Correlate expression with bacterial dissemination and persistence
Clinical isolate characterization:
Compare uspF expression patterns between clinical and environmental isolates
Correlate expression profiles with antibiotic resistance phenotypes
Investigate uspF mutations or expression variations in hypervirulent strains
These applications provide mechanistic insights into how stress responses contribute to bacterial pathogenicity and may identify new targets for antimicrobial development targeting stress adaptation pathways .